Mesenchymal stem cells for treatment of aortic aneurysms

Figure 2 Bone marrow-derived mesenchymal stem cell cell-sheet implantation or bone marrow-derived mesenchymal stem cell IV-administration attenuates aortic aneurysm progression and expansion. Aortic diameter was measured at the infrarenal aorta in the bone marrow-derived mesenchymal stem cell (BM-MSC) cell-sheet (A) or the BM-MSC IV-administration. Data are assessed by one-way ANOVA with Bonferroni correction. ^aP < 0.05 vs apoE^-/- group, ^cP < 0.05 vs apoE^-/- + ATII group. Data are from Hashizume et al[51] and Fu et al[53]. ATII: Angiotensin II; iv: Intravenous.